AzTrials
AzTrials

Partial Edentulism Class 1NCT05198687

Different Treatment Modalities for Atrophied Distal Extension Maxillary Ridges

A study testing Long implant and partial overdentures, Sinus lift and long implant and short implant without sinus lift in people with Partial Edentulism Class 1, run by Mansoura University at 1 site in Egypt.

Unknown status

Status not confirmed. The sponsor has not verified this record for over two years, so it may be out of date.

Official record
Search all trials

Trial summary

This study will compare clinical and radiographic outcomes of three different treatment modalities for atrophied distal extension maxillary ridges these modalities include 1. Implant retained distal extension RPD 2. Sinus lift and long implant and screw-retained prosthesis 3. Short implant and screw-retained prosthesis Read more about this study

Who is it for?
Any ageHealthy volunteers can take part
Conditions the study is for
Partial Edentulism Class 1
What is being tested?
Long implant and partial overdentures, Sinus lift and long implant and short implant without sinus lift
Could I receive a placebo?
No, everyone receives an active treatment
How many people
60 participants
Where
1 siteEgypt
Study dates
1 Mar 2020to 1 Jun 2022
Phase
Interventional
Are there results?
None posted in the registry

Key requirements

Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.

  • Ages Any age
  • All sexes
  • Healthy volunteers accepted
  • Child, Adult, Older adult

Who may be able to join

  • The patients will be selected according to the following:
  • They have distal extension maxillary ridge with sinus pneumatization and remaining alveolar bone height 6- 8mm as verified by preoperative CBCT, have no previous denture experience. They are healthy, free from any systemic diseases relating to the bone resorption (diabetes - hyperparathyroidism). This can be achieved through medical history and clinical examination by a physician and laboratory investigations.
  • Posterior maxillary alveolar ridge deficient in height, width and covered with healthy firm mucosa.
  • Patients are less satisfied with conventional RPD.
  • Absence of maxillary sinus diseases.

Who cannot join

  • Acute or chronic sinus pathology
  • History of a sinus augmentation in the past in the relevant sinus
  • Poor dental hygiene. Smoker.
  • Compromised general health (uncontrolled diabetes, bleeding disorder

Trial locations and contacts

1 site in 1 country.

Egypt1 site
  • Faculty of Dentistry, Mansoura University

    Al Mansurah, Eldakahlia, 35516

Other trials in Egypt

About this study

Official title: Comparison Between Three Different Treatment Modalities for Atrophied Distal Extension Maxillary Ridges Clinical and Radiographic Study

This study will compare clinical and radiographic outcomes of three different treatment modalities for atrophied distal extension maxillary ridges these modalities include

  1. Implant retained distal extension RPD
  2. Sinus lift and long implant and screw-retained prosthesis
  3. Short implant and screw-retained prosthesis
Read the detailed description

Patient selection:

For this study, 60 patients were selected from the clinic of Prosthodontic Department, Faculty of Dentistry, Mansoura University.

Inclusion criteria:

The patients will be selected according to the following:

  • They have distal extension maxillary ridge with sinus pneumatization and remaining alveolar bone height 6- 8mm as verified by preoperative CBCT, have no previous denture experience. They are healthy, free from any systemic diseases relating to the bone resorption (diabetes - hyperparathyroidism). This can be achieved through medical history and clinical examination by a physician and laboratory investigations.
  • Posterior maxillary alveolar ridge deficient in height, width and covered with healthy firm mucosa.
  • Patients are less satisfied with conventional RPD.
  • Absence of maxillary sinus diseases. Exclusion criteria

Patients were not eligible for this work if any of the following criteria were met:

  • Acute or chronic sinus pathology
  • History of a sinus augmentation in the past in the relevant sinus
  • Poor dental hygiene. Smoker.
  • Compromised general health (uncontrolled diabetes, bleeding disorder….). All patient were informed about all procedures that will be done and they sign the written consent form of ethical committee in faculty of dentistry Mansoura university.

Three treatment groups will be classified randomly, as follow:

  • Group A: patients received two implant in premolar area mesial to maxillary sinus and used to retain partial overdenture
  • Group B: patient underwent sinus lift and receive screw retained prosthesis on long implant
  • Group C: patients received short implants in premolar area mesial to maxillary sinus and received screw retained prothesis All implants were inserted using computer guided implant surgery and conventional loading protocol was used.

Evaluation methods Clinical and radiographic evaluation

  1. Modified Plaque index. Assessment of plaque accumulation with a modified plaque index (mPI): Score 0: No detection of plaque, Score 1: Plaque only recognized by running a probe across the smooth marginal surface of the implant, Score 2 Plaque can be seen by a naked eye, Score 3 Abundance of soft matter.
  2. Gingival index. Assessment of bleeding tendency with a modified sulcus bleeding index (mBI): Score 0 No bleeding when a periodontal probe is passed along the gingival margin adjacent to the implant. Score 1 Isolated bleeding spot visible, Score 2 Blood forms a confluent red line on margin, Score 3 Heavy or profuse bleeding.
  3. Attachment level. Distance from the junction implant/crown to the most apically probeable portion, in millimeters.
  4. Pocket depth. Distance between the gingival margin and the most apically probable portion, in millimeters Assessed by insertion of a standard periodontal probe with a point diameter of 0.5 mm using a probing force of 0.5 N.
  5. Implant stability quotient. Using resonance frequency analysis b- Radiographic evaluation will be performed in terms of: Vertical bone loss (VBL) will be evaluated as follows: The distance between implant plate form and first bone to implant contact (DIM) will be evaluated at T0, T6 and T12. VBL will be calculated by subtracting DIM at T6 and T12 from DIM at T0.
Being tested
Long implant and partial overdentures, Sinus lift and long implant, short implant without sinus lift, Partial overdentures, Metal ceramic prosthesis on long implants

What participants receive

What participants receive. In a randomised study each person is assigned to one group by chance.

  • Long implant and partial overdenturesProcedure or surgery

    insertion of long implants anterior to the maxillary sinus to retain partial overdentures

  • Sinus lift and long implantProcedure or surgery

    performing sinus lift surgical procedure with simultaneous placement of long implants to support screw-retained prosthesis

  • short implant without sinus liftProcedure or surgery

    placement of short implants in the remaining bone above maxillary sinus to support screw-retained prosthesis without performing sinus lift

  • Partial overdenturesDevice

    Distal extension metallic partial dentures retained by attachments to the implants

  • Metal ceramic prosthesis on long implantsDevice

    porcelain fused to metal fixed screw-retained prosthesis supported by long implants

  • Metal ceramic prosthesis on short implantsDevice

    porcelain fused to metal fixed screw-retained prosthesis supported by short implants

Study groups in NCT05198687
Study groupRoleWhat they receive
overdenturesActive comparatorimplant overdentures
Receives: Procedure: Long implant and partial overdentures; Device: Partial overdentures
sinus liftActive comparatorsinus lift and long implants and screw-retained prosthesis
Receives: Procedure: Sinus lift and long implant; Device: Metal ceramic prosthesis on long implants
short implantsActive comparatorshort implants and screw-retained prosthesis
Receives: Procedure: short implant without sinus lift; Device: Metal ceramic prosthesis on short implants

What is being measured

The primary outcome is the main question the study is designed to answer.

  1. Plaque index

    measuring plaque accumulation around implants using scores

    Measured: one year

  2. Gingival index

    measuring gingival inflammation around implants using scores

    Measured: one year

  3. Probing depth

    measuring peri-implant probing depth in mm

    Measured: one year

  4. implant stability

    measuring the mobility of the implants using resonance frequency analysis Implant stability quotient)

    Measured: one year

  5. Marginal bone loss

    measuring crestal bone loss around implants in mm

    Measured: one year

  6. Patient satisfaction using VAS questionnaire (visual analogue scale)

    Regarding VAS, participants were asked to score their answer according to the amount of satisfaction on a 100mm line (Score zero = no satisfaction at all and score 100 = complete satisfaction). The questions cover several items related to prosthesis such as: retention, stability, comfort, ease of cleaning, ease of speaking, ease of chewing, limited activities due to embarrassment, quality of bolus and appearance.

    Measured: one year

Secondary outcomes (3)
  1. Prosthetic Aspects

    measuring the incidence of prosthetic aspects and maintenance requirements

    Measured: one year

  2. Muscle activity

    measure muscles activity in amplitude using electromyographs

    Measured: one year

  3. maximum bite force

    measuring maximum bite force in newton using bite force transducers

    Measured: one year

Timeline

From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.

  1. First posted20 Jan 2022
  2. Study start1 Mar 2020
  3. Primary completion1 May 2021
  4. Study completion1 Jun 2022 (estimated)

Resources

More details

For doctors and researchers: how the study is designed, who runs it, and its registry IDs.

Study design
Study type
Interventional
Phase
Phase N/A
Primary purpose
Treatment
Allocation
Randomised
Intervention model
Parallel groups
Masking
Double blind
Who is masked
Participant, Outcomes assessor
Enrolment
60 participants (actual)
IDs, dates and publications
ClinicalTrials.gov ID
NCT05198687
Sponsor's protocol ID
M06030320
Status last verified
Sep 2021
First submitted
24 Sep 2021
Last updated
2 Mar 2022
Results posted
No
Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
No
Individual data sharing
Yes

Questions about this trial

What is this clinical trial studying?

A study testing Long implant and partial overdentures, Sinus lift and long implant and short implant without sinus lift in people with Partial Edentulism Class 1, run by Mansoura University at 1 site in Egypt.

The full registered description is in the About this study section and the official record.

Who may be eligible to take part?

The sponsor lists 5 inclusion and 4 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.

Is this clinical trial currently recruiting?

The record says: status not confirmed, as of the sponsor's last update on 2 Mar 2022. Status can change between updates, so confirm with the study contact before making plans.

Where is the study taking place?

The record lists 1 site in Egypt. Whether a site is taking part right now should be confirmed with that site. See every site.

What are the possible benefits and risks?

They depend on the study and the treatment, and no study can promise a benefit. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.

Are results available for this study?

Results are not available in the source record.

How can a doctor refer a patient or contact the research team?

The record lists no contact. The official record names the sponsor, who can be asked directly. AzTrials does not enrol participants or take referrals.

What does the primary outcome measure?

Plaque index (time frame: one year). The study lists 6 primary outcomes in all. It is what the study was designed to measure, not a finding.

Where can I read the original study information?
Does a listing mean the treatment is approved or proven to work?

No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.

How often is this information updated?

AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 2 Mar 2022.

Free account

Log in to keep searching

You’ve used your 3 free searches. AzTrials is free: log in or create a free account to keep searching clinical trials and save the ones you want to follow.

Create a free accountLog in